Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F de Braud

Showing results (101-110 of 120) with videos related to

Pageof 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2000
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancerA de Gramont, A Figer, M Seymour, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2023
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal CancerA de Gramont, A Figer, M Seymour, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2016
Toward the molecular dissection of peritoneal pseudomyxomaF Pietrantonio, F Perrone, A Mennitto, et al.
Ecancermedicalscience|January 26, 2012
Institutional guidelines and ongoing studies in management of liver tumours: the experience of the European Institute of OncologyR Biffi, F Orsi, M G Zampino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 13, 2014
Radiotherapy or chemotherapy for clinical stage IIA and IIB seminoma: a systematic review and meta-analysis of patient outcomesP Giannatempo, T Greco, L Mariani, et al.
Cytokine & Growth Factor Reviews|November 6, 2018
Innovative therapy, monoclonal antibodies, and beyond: Highlights from the eighth annual meetingF De Santis, M Del Vecchio, L Castagnoli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
Negative hyper-selection of metastatic colorectal cancer patients for anti-EGFR monoclonal antibodies: the PRESSING case-control studyC Cremolini, F Morano, R Moretto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 7, 2010
A phase I study to determine the safety, pharmacokinetics and pharmacodynamics of a dual VEGFR and FGFR inhibitor, brivanib, in patients with advanced or metastatic solid tumorsD J Jonker, L S Rosen, M B Sawyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 4, 2018
Temozolomide and irinotecan (TEMIRI regimen) as salvage treatment of irinotecan-sensitive advanced colorectal cancer patients bearing MGMT methylationF Morano, S Corallo, M Niger, et al.
International Journal of Cancer|September 1, 2016
HER2 loss in HER2-positive gastric or gastroesophageal cancer after trastuzumab therapy: Implication for further clinical researchF Pietrantonio, M Caporale, F Morano, et al.
Pageof 12

Showing results (101-110 of 120) with videos related to

Sort By:
Pageof 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2000
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancerA de Gramont, A Figer, M Seymour, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2023
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal CancerA de Gramont, A Figer, M Seymour, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2016
Toward the molecular dissection of peritoneal pseudomyxomaF Pietrantonio, F Perrone, A Mennitto, et al.
Ecancermedicalscience|January 26, 2012
Institutional guidelines and ongoing studies in management of liver tumours: the experience of the European Institute of OncologyR Biffi, F Orsi, M G Zampino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 13, 2014
Radiotherapy or chemotherapy for clinical stage IIA and IIB seminoma: a systematic review and meta-analysis of patient outcomesP Giannatempo, T Greco, L Mariani, et al.
Cytokine & Growth Factor Reviews|November 6, 2018
Innovative therapy, monoclonal antibodies, and beyond: Highlights from the eighth annual meetingF De Santis, M Del Vecchio, L Castagnoli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
Negative hyper-selection of metastatic colorectal cancer patients for anti-EGFR monoclonal antibodies: the PRESSING case-control studyC Cremolini, F Morano, R Moretto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 7, 2010
A phase I study to determine the safety, pharmacokinetics and pharmacodynamics of a dual VEGFR and FGFR inhibitor, brivanib, in patients with advanced or metastatic solid tumorsD J Jonker, L S Rosen, M B Sawyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 4, 2018
Temozolomide and irinotecan (TEMIRI regimen) as salvage treatment of irinotecan-sensitive advanced colorectal cancer patients bearing MGMT methylationF Morano, S Corallo, M Niger, et al.
International Journal of Cancer|September 1, 2016
HER2 loss in HER2-positive gastric or gastroesophageal cancer after trastuzumab therapy: Implication for further clinical researchF Pietrantonio, M Caporale, F Morano, et al.
Pageof 12